Kennedy Appears Ill-Informed On Major Pharma Priorities, Creating Unique Lobbying Dynamics

 
• By Sarah Karlin-Smith
Robert F. Kennedy Jr.
HHS Secretary Robert F. Kennedy Jr.'s lack of knowledge on key industry policy asks may impact lobbying strategy. (lev radin / Shutterstock)

More from Pricing Debate

More from US FDA